Trial
NCT01559103
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Rheumatoid Arthritis
Intervention
MEDI5117
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-09